ALICOSINUM
Live / Registered — Registered (as of 28 Feb 2023)
What this means for you
Registered since 28 Feb 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Feb 2029: the §8 declaration of use).
Record
- Serial number
- 97253156
- Registration number
- 6991448
- Mark type
- Word mark
- Filed
- 04 Feb 2022
- Published for opposition
- 13 Dec 2022
- Registered
- 28 Feb 2023
- Next maintenance filing
- §8 declaration of use, due by 28 Feb 2029 (grace period to 28 Aug 2029)
- Attorney of record
- Nyall Engfield
Goods and services
- Class 005 — Pharmaceuticals: Homeopathic pharmaceuticals for use in the treatment of flu and flu-like symptoms, namely, body aches, headaches, fever, sore throat, tiredness and chills
Owner
- Pharmaris Canada Inc., Surrey BC, CA
- Pharmaris Canada Inc., Surrey BC, CA
- Pharmaris Canada Inc., Surrey BC, CA
Prosecution history
- 28 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Nov 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 04 Nov 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 29 Oct 2022 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 28 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Oct 2022 — USE AMENDMENT ACCEPTED
- 10 Oct 2022 — AMENDMENT TO USE PROCESSING COMPLETE
- 10 Oct 2022 — USE AMENDMENT FILED
- 08 Oct 2022 — TEAS AMENDMENT OF USE RECEIVED
- 03 Oct 2022 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 25 Sept 2022 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED